These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

354 related articles for article (PubMed ID: 38317842)

  • 61. The sorafenib resistance-related gene signature predicts prognosis and indicates immune activity in hepatocellular carcinoma.
    Luo T; Chen X; Pan W; Zhang S; Huang J
    Cell Cycle; 2024 Jan; 23(2):150-168. PubMed ID: 38444181
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Disulfidptosis-related signature predicts prognosis and characterizes the immune microenvironment in hepatocellular carcinoma.
    Tang J; Peng X; Xiao D; Liu S; Tao Y; Shu L
    Cancer Cell Int; 2024 Jan; 24(1):19. PubMed ID: 38195525
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Crosstalk of disulfidptosis-related subtypes, establishment of a prognostic signature and immune infiltration characteristics in bladder cancer based on a machine learning survival framework.
    Zhao S; Wang L; Ding W; Ye B; Cheng C; Shao J; Liu J; Zhou H
    Front Endocrinol (Lausanne); 2023; 14():1180404. PubMed ID: 37152941
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Construction and validation of a novel signature based on epithelial-mesenchymal transition-related genes to predict prognosis and immunotherapy response in hepatocellular carcinoma by comprehensive analysis of the tumor microenvironment.
    Gao B; Wang Y; Lu S
    Funct Integr Genomics; 2022 Dec; 23(1):6. PubMed ID: 36536232
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Exploration and validation of a combined Hypoxia and m6A/m5C/m1A regulated gene signature for prognosis prediction of liver cancer.
    Ren M; Fan B; Cao G; Zong R; Feng L; Sun H
    BMC Genomics; 2023 Dec; 24(1):776. PubMed ID: 38097948
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Establishment and Evaluation of Exosomes-Related Gene Risk Model in Hepatocellular Carcinoma.
    Zhu L; Lou Y; Xiao Q; Wang L; Chen G; Yang W; Wang T
    Biochem Genet; 2024 Apr; 62(2):698-717. PubMed ID: 37405532
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Identification of m6A- and ferroptosis-related lncRNA signature for predicting immune efficacy in hepatocellular carcinoma.
    Xie H; Shi M; Liu Y; Cheng C; Song L; Ding Z; Jin H; Cui X; Wang Y; Yao D; Wang P; Yao M; Zhang H
    Front Immunol; 2022; 13():914977. PubMed ID: 36032107
    [TBL] [Abstract][Full Text] [Related]  

  • 68. An immune-related signature for optimizing prognosis prediction and treatment decision of hepatocellular carcinoma.
    Yao N; Jiang W; Wang Y; Song Q; Cao X; Zheng W; Zhang J
    Eur J Med Res; 2023 Mar; 28(1):123. PubMed ID: 36918943
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Mitochondrial-Related Transcriptome Feature Correlates with Prognosis, Vascular Invasion, Tumor Microenvironment, and Treatment Response in Hepatocellular Carcinoma.
    Wang Y; Song F; Zhang X; Yang C
    Oxid Med Cell Longev; 2022; 2022():1592905. PubMed ID: 35535359
    [TBL] [Abstract][Full Text] [Related]  

  • 70. A novel immunogenic cell death-related genes signature for predicting prognosis, immune landscape and immunotherapy effect in hepatocellular carcinoma.
    Xu G; Jiang Y; Li Y; Ge J; Xu X; Chen D; Wu J
    J Cancer Res Clin Oncol; 2023 Dec; 149(18):16261-16277. PubMed ID: 37698679
    [TBL] [Abstract][Full Text] [Related]  

  • 71. A prognostic model for hepatocellular carcinoma patients based on signature ferroptosis-related genes.
    Wan S; Lei Y; Li M; Wu B
    Hepatol Int; 2022 Feb; 16(1):112-124. PubMed ID: 34449009
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Cuproptosis-associated genes (CAGs) contribute to the prognosis prediction and potential therapeutic targets in hepatocellular carcinoma.
    Shi X; Shi D; Yin Y; Wu Y; Chen W; Yu Y; Wang X
    Cell Signal; 2024 May; 117():111072. PubMed ID: 38307306
    [TBL] [Abstract][Full Text] [Related]  

  • 73. A Novel Ferroptosis-Related Signature for Prediction of Prognosis, Immune Profiles and Drug Sensitivity in Hepatocellular Carcinoma Patients.
    Zhao C; Zhang Z; Tao J
    Curr Oncol; 2022 Sep; 29(10):6992-7011. PubMed ID: 36290827
    [TBL] [Abstract][Full Text] [Related]  

  • 74. An 8-gene predicting survival model of hepatocellular carcinoma (HCC) related to pyroptosis and cuproptosis.
    Wang H; Wang N; Tang Z; Liu Q; Nie S; Tao W
    Hereditas; 2023 Jul; 160(1):30. PubMed ID: 37464443
    [TBL] [Abstract][Full Text] [Related]  

  • 75. A novel prognostic index of hepatocellular carcinoma based on immunogenomic landscape analysis.
    Xiao H; Wang B; Xiong HX; Guan JF; Wang J; Tan T; Lin K; Zou SB; Hu ZG; Wang K
    J Cell Physiol; 2021 Apr; 236(4):2572-2591. PubMed ID: 32853412
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Identification and validation of a fatty acid metabolism-related lncRNA signature as a predictor for prognosis and immunotherapy in patients with liver cancer.
    Chen E; Yi J; Jiang J; Zou Z; Mo Y; Ren Q; Lin Z; Lu Y; Zhang J; Liu J
    BMC Cancer; 2022 Oct; 22(1):1037. PubMed ID: 36195833
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Signature construction and molecular subtype identification based on immune-related genes for better prediction of prognosis in hepatocellular carcinoma.
    Sun L; Wu Z; Dong C; Yu S; Huang H; Chen Z; Wu Z; Yin X
    BMC Med Genomics; 2023 Jun; 16(1):130. PubMed ID: 37316840
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Development of a novel disulfidptosis-related lncRNA signature for prognostic and immune response prediction in clear cell renal cell carcinoma.
    Wang N; Hu Y; Wang S; Xu Q; Jiao X; Wang Y; Yan L; Cao H; Shao F
    Sci Rep; 2024 Jan; 14(1):624. PubMed ID: 38182642
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Construction of a Novel LncRNA Signature Related to Genomic Instability to Predict the Prognosis and Immune Activity of Patients With Hepatocellular Carcinoma.
    Zhu J; Huang Q; Liu S; Peng X; Xue J; Feng T; Huang W; Chen Z; Lai K; Ji Y; Wang M; Yuan R
    Front Immunol; 2022; 13():856186. PubMed ID: 35479067
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Identification of immune cell-related prognostic genes characterized by a distinct microenvironment in hepatocellular carcinoma.
    Li MT; Zheng KF; Qiu YE
    World J Clin Oncol; 2024 Feb; 15(2):243-270. PubMed ID: 38455128
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.